These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9246907)

  • 61. Protection of normal cells and tissues during radio- and chemosensitization of tumors by 2-deoxy-D-glucose.
    Farooque A; Afrin F; Adhikari JS; Dwarakanath BS
    J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S32-5. PubMed ID: 20009291
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Biological rationale and clinical experience with hyperthermia.
    Engin K
    Control Clin Trials; 1996 Aug; 17(4):316-42. PubMed ID: 8889346
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical exploitation of biological phenomena in combined radiotherapy (RT) and local hyperthermia (HT).
    Arcangeli G
    Prog Clin Biol Res; 1983; 132D():217-34. PubMed ID: 6634796
    [No Abstract]   [Full Text] [Related]  

  • 64. Biological rationales and clinical applications of temperature controlled hyperthermia--implications for multimodal cancer treatments.
    Schildkopf P; Ott OJ; Frey B; Wadepohl M; Sauer R; Fietkau R; Gaipl US
    Curr Med Chem; 2010; 17(27):3045-57. PubMed ID: 20629627
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Role of nonspecific factors in the therapeutic action of general hyperthermia in oncologic diseases].
    Balliuzek FV; Sokolovskiĭ VV; Dzhaginian AI; Baskovich GA; Gaĭkova ON
    Med Radiol (Mosk); 1987 May; 32(5):47-9. PubMed ID: 3586923
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The biological bases for the clinical application of hyperthermia as an adjuvant to radiotherapy.
    Overgaard J
    Prog Clin Biol Res; 1983; 132D():205-16. PubMed ID: 6634795
    [No Abstract]   [Full Text] [Related]  

  • 67. [Outlines for the combination of hyperthermia therapy and radiotherapy in clinical oncology with special reference to the reciprocal action moment].
    Bistolfi F
    Minerva Med; 1981 May; 72(20):1255-66. PubMed ID: 7017474
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Has hyperthermia a place in cancer treatment?
    Dunlop PR; Howard GC
    Clin Radiol; 1989 Jan; 40(1):76-82. PubMed ID: 2646062
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [The mechanisms of the cytotoxic action of hyperthermia].
    Mircheva I
    Eksp Med Morfol; 1991; 30(1):51-4. PubMed ID: 1884689
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A new approach to microwave hyperthermia therapy for cancer.
    Heinmets F
    Physiol Chem Phys; 1981; 13(6):561-4. PubMed ID: 7346870
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of hyperthermia as a mitigation strategy in DNA damage-based cancer therapies.
    Mantso T; Goussetis G; Franco R; Botaitis S; Pappa A; Panayiotidis M
    Semin Cancer Biol; 2016 Jun; 37-38():96-105. PubMed ID: 27025900
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Basic science research in thermal ablation.
    Ahmed M; Goldberg SN
    Surg Oncol Clin N Am; 2011 Apr; 20(2):237-58, vii. PubMed ID: 21377581
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Chain reaction in destruction of cancer cell-current status of research on the "cancer multiple-step therapy" concept].
    von Ardenne M
    Elektromed Biomed Tech; 1969 Sep; 14(5):184-8. PubMed ID: 5409307
    [No Abstract]   [Full Text] [Related]  

  • 74. Hyperthermia: a developing modality with potential for clinical application.
    Luk KH; Valencia T
    Radiol Technol; 1983; 54(4):267-9. PubMed ID: 6856806
    [No Abstract]   [Full Text] [Related]  

  • 75. Simulation techniques in hyperthermia treatment planning.
    Paulides MM; Stauffer PR; Neufeld E; Maccarini PF; Kyriakou A; Canters RA; Diederich CJ; Bakker JF; Van Rhoon GC
    Int J Hyperthermia; 2013 Jun; 29(4):346-57. PubMed ID: 23672453
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A patterns of care analysis of hyperthermia in combination with radio(chemo)therapy or chemotherapy in European clinical centers.
    Ademaj A; Veltsista PD; Marder D; Hälg RA; Puric E; Brunner TB; Crezee H; Gabrys D; Franckena M; Gani C; Horsman MR; Krempien R; Lindner LH; Maluta S; Notter M; Petzold G; Abdel-Rahman S; Richetti A; Thomsen AR; Tsoutsou P; Fietkau R; Ott OJ; Ghadjar P; Riesterer O
    Strahlenther Onkol; 2023 May; 199(5):436-444. PubMed ID: 36038671
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hyperthermia device approved for limited cancer treatment.
    FDA Drug Bull; 1984 Apr; 14(1):6. PubMed ID: 6734994
    [No Abstract]   [Full Text] [Related]  

  • 78. Workshop conference on hyperthermia on cancer treatment. Tucson, Arizona, March 19-21, 1984. Proceedings.
    Cancer Res; 1984 Oct; 44(10 Suppl):4704s-908s. PubMed ID: 6467223
    [No Abstract]   [Full Text] [Related]  

  • 79. Integrating Hyperthermia into Modern Radiation Oncology: What Evidence Is Necessary?
    Peeken JC; Vaupel P; Combs SE
    Front Oncol; 2017; 7():132. PubMed ID: 28713771
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hyperthermia in the treatment of cancer.
    Baker ML; Mabry CD
    J Ark Med Soc; 1981 Jul; 78(2):97-9. PubMed ID: 6455411
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.